BANK VONTOBEL AG | Market Closed - Swiss Exchange 11:20:00 2024-06-03 am EDT | ||
| 99.2 USD | +0.30% |
|
| 1 month | -1.29% | ||
| 3 months | -1.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 99.2 | +0.30% |
| 24-05-29 | 98.9 | -0.60% |
Delayed Quote Swiss Exchange
Last update June 03, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| RMBVTV | |
| ISIN | CH1308709075 |
| Date issued | 2023-12-14 |
| Strike | 282.6 $ |
| Maturity | 2025-12-15 (560 Days) |
| Parity | 0.28 : 1 |
| Emission price | 98 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.5 $ |
|---|---|
| Lowest since issue | 96.6 $ |
| Spread | 8.1 $ |
| Spread % | 0.81% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Certificates
- RMBVTV Certificat
